Loading
Latest filing published 03 Jul 2025 for X4 Pharmaceuticals, Inc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 3 July 2025, Natasha Fay Thoren disclosed a share grant in X4 Pharmaceuticals, Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration